M
Marietta Memorial Hospital | Department of Rheumatology
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Upadacitinib
ABBV-105
ABBV-599
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 6 total trials
The purpose of this study is to compare the safety and efficacy of risankizumab versus placebo in participants with moderately to severely active pso...
Active, not recruiting
Psoriatic Arthritis
Biological: Placebo
Biological: Risankizumab
This protocol includes 2 standalone studies with randomization, data collection, analysis and reporting conducted independently.The main objectives o...
Active, not recruiting
Spondyloarthritis
Drug: Placebo
Drug: Upadacitinib
This study consists of two periods. The objective of Period 1 is to evaluate the efficacy of upadacitinib in combination with a 26-week corticosteroi...
Active, not recruiting
Giant Cell Arteritis (GCA)
Drug: Upadacitinib
Other: Placebo
Trial sponsors
U
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems